| Josiah Stephen Ziegler, DO | |
|
1008 Patton St, Fort Collins, CO 80524-4018 | |
| (970) 494-4200 | |
| (970) 399-8038 |
| Full Name | Josiah Stephen Ziegler |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 3 Years |
| Location | 1008 Patton St, Fort Collins, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144753161 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | DR.0066043 (Colorado) | Primary |
| Entity Name | Denver Health And Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477569838 PECOS PAC ID: 4688583578 Enrollment ID: O20031105000211 |
News Archive
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment of the neurological complications of diabetes, today reported business and financial highlights for the second quarter ended June 30, 2013.
McClatchy: "The U.S. Conference of Catholic Bishops said Monday it opposes the Democratic health care plan heading for a vote in the U.S. House of Representatives because of its language on abortion. The group noted that it liked the House health care bill because it would continue the strict ban on federal financing of abortion.
Data presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, Mass., reinforced the benefit for employers to acknowledge and assess the impact of migraine to potentially improve workplace productivity.
Scientists at The University of Texas M. D. Anderson Cancer Center have identified a protein that serves as a master regulator of skin cancer - a finding that could lead to new ways to prevent skin cancer before it starts.
Cardium Therapeutics today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform.
› Verified 2 days ago
| Entity Name | Poudre Valley Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760492714 PECOS PAC ID: 7618880709 Enrollment ID: O20031105000791 |
News Archive
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment of the neurological complications of diabetes, today reported business and financial highlights for the second quarter ended June 30, 2013.
McClatchy: "The U.S. Conference of Catholic Bishops said Monday it opposes the Democratic health care plan heading for a vote in the U.S. House of Representatives because of its language on abortion. The group noted that it liked the House health care bill because it would continue the strict ban on federal financing of abortion.
Data presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, Mass., reinforced the benefit for employers to acknowledge and assess the impact of migraine to potentially improve workplace productivity.
Scientists at The University of Texas M. D. Anderson Cancer Center have identified a protein that serves as a master regulator of skin cancer - a finding that could lead to new ways to prevent skin cancer before it starts.
Cardium Therapeutics today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform.
› Verified 2 days ago
| Entity Name | Summitstone Health Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821552738 PECOS PAC ID: 4284527144 Enrollment ID: O20040204000768 |
News Archive
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment of the neurological complications of diabetes, today reported business and financial highlights for the second quarter ended June 30, 2013.
McClatchy: "The U.S. Conference of Catholic Bishops said Monday it opposes the Democratic health care plan heading for a vote in the U.S. House of Representatives because of its language on abortion. The group noted that it liked the House health care bill because it would continue the strict ban on federal financing of abortion.
Data presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, Mass., reinforced the benefit for employers to acknowledge and assess the impact of migraine to potentially improve workplace productivity.
Scientists at The University of Texas M. D. Anderson Cancer Center have identified a protein that serves as a master regulator of skin cancer - a finding that could lead to new ways to prevent skin cancer before it starts.
Cardium Therapeutics today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform.
› Verified 2 days ago
| Entity Name | Psychiatric Services Of The Rockies Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427776236 PECOS PAC ID: 1456716018 Enrollment ID: O20230503002963 |
News Archive
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment of the neurological complications of diabetes, today reported business and financial highlights for the second quarter ended June 30, 2013.
McClatchy: "The U.S. Conference of Catholic Bishops said Monday it opposes the Democratic health care plan heading for a vote in the U.S. House of Representatives because of its language on abortion. The group noted that it liked the House health care bill because it would continue the strict ban on federal financing of abortion.
Data presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, Mass., reinforced the benefit for employers to acknowledge and assess the impact of migraine to potentially improve workplace productivity.
Scientists at The University of Texas M. D. Anderson Cancer Center have identified a protein that serves as a master regulator of skin cancer - a finding that could lead to new ways to prevent skin cancer before it starts.
Cardium Therapeutics today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Josiah Stephen Ziegler, DO 4856 Innovation Dr Ste B, Fort Collins, CO 80525-5540 Ph: (970) 494-4200 | Josiah Stephen Ziegler, DO 1008 Patton St, Fort Collins, CO 80524-4018 Ph: (970) 494-4200 |
News Archive
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment of the neurological complications of diabetes, today reported business and financial highlights for the second quarter ended June 30, 2013.
McClatchy: "The U.S. Conference of Catholic Bishops said Monday it opposes the Democratic health care plan heading for a vote in the U.S. House of Representatives because of its language on abortion. The group noted that it liked the House health care bill because it would continue the strict ban on federal financing of abortion.
Data presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) in Boston, Mass., reinforced the benefit for employers to acknowledge and assess the impact of migraine to potentially improve workplace productivity.
Scientists at The University of Texas M. D. Anderson Cancer Center have identified a protein that serves as a master regulator of skin cancer - a finding that could lead to new ways to prevent skin cancer before it starts.
Cardium Therapeutics today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform.
› Verified 2 days ago
Nora Feldpausch, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5525 Trail Pt, Fort Collins, CO 80524 Phone: 989-640-1063 | |
Dr. Jillian Leigh Busch, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4601 Corbett Dr, Fort Collins, CO 80528 Phone: 970-207-4857 Fax: 970-207-4885 | |
Dr. Brian Lee Kaiser, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1106 E Prospect Rd, Suite 100, Fort Collins, CO 80525 Phone: 970-482-4373 Fax: 970-484-5682 | |
Zeljko M Ivanovic, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 120 Bristlecone Dr, Fort Collins, CO 80524 Phone: 970-224-5209 | |
Dr. Kathleen P Whitley, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4856 Innovation Dr Ste B, Fort Collins, CO 80525 Phone: 970-494-4200 | |
Dr. Keri Lee Lemmond, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4803 Boardwalk Dr Ste 120, Fort Collins, CO 80525 Phone: 970-310-3406 Fax: 888-965-4615 | |
Donald A Golen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2315 E Harmony Rd Ste 110, Fort Collins, CO 80528 Phone: 970-482-4373 Fax: 970-484-5682 |